Case Report: Severe Pneumocystis jirovecii pneumonia following zuberitamab treatment in autoimmune hemolytic anemia

Case Report: Severe Pneumocystis jirovecii pneumonia following zuberitamab treatment in autoimmune hemolytic anemia

The pathogenesis of autoimmune hemolytic anemia (AIHA) remains incompletely understood, typically associated with immune dysfunction and the production of autoantibodies. Zuberitamab, a novel anti-CD20 monoclonal antibody, represents an important therapeutic strategy for managing autoimmune diseases...

Full description

Saved in:
Bibliographic Details
Main Authors: Qian Yang, Peng Ding, Yu-xiang Liu, Kai-chen Zhang, Pei-yang Gao
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Immunology
Subjects:
autoimmune hemolytic anemia
autoimmune diseases
zuberitamab
B-cell depletion
severe Pneumocystis jirovecii pneumonia
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1546571/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items